$ACNB

Seibel Donald Arthur Jr sold $97K of ACNB

Seibel Donald Arthur Jr sold 1,500 shares of ACNB CORP (ACNB) at $64.35 on 2026-08-07.

Original reporting
SEC EDGAR · Seibel Donald Arthur Jr
Published Aug 7, 2026, 7:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 7:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ACNB
Neutral
medium confidence
Mentioned
$ACNB
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACNBNeutralLow
01

Why it matters

The newest disclosed fact is the director’s sale details (1,500 shares at $64.35, total $96,525) and post-sale holdings (5,312 shares).

02

Market read

Traders may note the insider sale for sentiment monitoring, but there is no accompanying company-specific catalyst in the text.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs; the filing lacks context on motivations and is small relative to typical institutional flows.

Relevance 3/10Novelty 3/10Timing: filed 2026-08-07, after-hours disclosure window

Background

The article is a SEC Form 4 insider transaction filing for ACNB, reported by a director.

Company-level read

Ticker impact

$ACNBNeutralMedium confidence
Context

ACNB director Seibel Donald Arthur Jr filed a Form 4 showing an open-market sale of 1,500 shares at $64.35 on 2026-08-07.

Expected impact

Likely limited near-term impact; treat as low-signal unless accompanied by broader insider selling trends or company-specific news.

Evidence & confidence

Form 4 insider sales are common and often non-informational; the article provides transaction size and price but no accompanying corporate or guidance catalyst.

Market effects

No sector-level implications from a single director’s small open-market sale.

None indicated.

None indicated.

Counterpoint

The absence of a pre-arranged 10b5-1 plan could be interpreted as potentially more discretionary selling, which some traders may read as mild bearish sentiment.

Key entities

  • ACNB CORP

    Public company whose director insider sale is disclosed via SEC Form 4.

  • Seibel Donald Arthur Jr

    Director reporting an open-market sale of ACNB shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACNBHigh

ACNB CORP (ACNB): We are pleased to report the strongest quarterly earnings performance in our Company's 169-year history, reflecting the enduring strength of our community…

ACNB CORP (ACNB) filed an SEC Form 8-K — Results of Operations and Financial Condition. PRESS RELEASE FOR IMMEDIATE RELEASE Contact: Jason H. Weber EVP/Treasurer & Chief Financial Officer 717.339.5090 jweber@acnb.com ACNB CORPORATION REPORTS RECORD 2026 THIRD QUARTER FINANCIAL RESULTS GETTYSBURG, PA, October 22, 2026 --- ACNB Corporation (NASDAQ: ACNB) (“ACNB” or th

$ACNBMed

ACNB CORP (ACNB): Results of Operations and Financial Condition

ACNB CORP (ACNB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 pressrelease2026-q2.htm EX-99.1 pressrelease2026-q2 PRESS RELEASE FOR IMMEDIATE RELEASE Contact: Jason H. Weber EVP/Treasurer & Chief Financial Officer 717.339.5090 jweber@acnb.com ACNB CORPORATION REPORTS RECORD 2026 SECOND QUARTER FINANCIAL RESULTS GETTYSBURG, PA, Jul

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).